Phoenix Biotech Acquisiti... (PBAX)
NASDAQ: PBAX
· Real-Time Price · USD
5.85
0.37 (6.75%)
At close: Feb 14, 2024, 9:56 PM
Phoenix Biotech Acquisition Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Revenue | n/a | n/a | n/a | n/a | 254.83K | 254.83K | 254.83K | 254.83K | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | 254.83K | 254.83K | 254.83K | 254.83K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -28.99M | -24.47M | -11.52M | -7.71M | -2.19M | -1.61M | -178.88K | -378B | -378B | -378B | -378B | -332.03K | n/a |
Interest Income | -380.58K | -259.06K | 272.03K | 380.58K | 380.58K | 579.53K | 466.14K | 357.58K | 357.58K | 37.11K | n/a | n/a | n/a |
Pretax Income | -21.04M | -15.89M | -8.38M | -4.63M | -1.91M | -1.45M | -172.29K | -68.58K | -677.01K | -821.98K | -710.41K | -332.42K | n/a |
Net Income | -21.08M | -15.95M | -8.45M | -4.59M | -2.41M | -1.99M | -890.8K | 378B | 378B | 378B | 378B | -315.55K | n/a |
Selling & General & Admin | 13.7M | 12.09M | 7.01M | 4.95M | 3.89M | 4.25M | 3.05M | 2.84M | 1.72M | 933.06K | 606.48K | 251.71K | n/a |
Research & Development | 14.48M | 11.57M | 4.49M | 2.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -2.1K | -2.1K | -22.7K | 1K | -84.95K | -34.95K | 37.75K | 64.05K | 150K | 100K | 50K | n/a | n/a |
Operating Expenses | 28.18M | 23.66M | 11.52M | 7.71M | 3.85M | 4.26M | 3.09M | 2.91M | 1.95M | 1.11M | 736.81K | 332.03K | n/a |
Interest Expense | -16.13K | -16.98K | -16.98K | -16.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 13.68M | 14.11M | 1.97M | 2.56M | 3.85M | 4.26M | 3.09M | 2.91M | 1.95M | 1.11M | 736.81K | 332.03K | n/a |
Income Tax Expense | 38.15K | 63.9K | 70.41K | -38.15K | 500.55K | 535.26K | 718.51K | -378B | -378B | -378B | -378B | -16.87K | n/a |
Shares Outstanding (Basic) | 49.68M | 49.68M | 49.68M | 48.6M | 56.99M | 60.93M | 60.93M | 63.08M | 68.94M | 68.94M | 68.94M | 68.94M | 68.94M |
Shares Outstanding (Diluted) | 49.68M | 49.68M | 49.68M | 48.6M | 56.99M | 60.93M | 60.93M | 63.08M | 68.94M | 68.94M | 68.94M | 68.94M | 68.94M |
EPS (Basic) | -0.43 | -0.32 | -0.16 | -0.09 | -0.04 | -0.03 | -0.01 | 5.48K | 5.48K | 5.48K | 5.48K | -0.00 | n/a |
EPS (Diluted) | -0.43 | -0.32 | -0.16 | -0.09 | -0.04 | -0.03 | -0.01 | 5.48K | 5.48K | 5.48K | 5.48K | -0.00 | n/a |
EBITDA | -22.71M | -18.19M | -11.52M | -7.71M | -5.77M | -6.84M | -5.9M | -5.74M | -2.87M | -1.37M | -763.59K | -332.03K | n/a |
EBIT | n/a | -429.8K | -429.8K | -429.8K | -51.8K | 522.96K | 411.39K | -378B | -378B | -378B | -378B | n/a | n/a |
Depreciation & Amortization | 695.93K | -163.67K | -737.52K | -695.93K | -4.28M | -5.07M | -5.68M | 377.99B | 377.99B | 378B | 378B | 125.39K | 54K |